Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.12% Nasdaq Down0.07%

Endocyte, Inc. (ECYT)

-NasdaqGS

14.16 May 20, 4:00PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.7
Mean Recommendation (last week):1.7
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:16.83
Median Target:16.50
High Target:20.00
Low Target:14.00
No. of Brokers:6

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 24, 2013Robert W. BairdUpgradeNeutralOutperform
Nov 19, 2012Summer Street ResearchInitiated Buy
Mar 16, 2011RBC Capital MktsInitiated Outperform
Mar 15, 2011Robert W. BairdInitiated Outperform
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3323
Buy3332
Hold1122
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.